Eurekam

Lagord, France Founded: 2012 • Age: 14 yrs
AI-based medication management solutions for oncology professionals are provided.

About Eurekam

Eurekam is a company based in Lagord (France) founded in 2012 by Loic Tamarelle and Benoit Le Franc. Eurekam has raised $8.84 million across 3 funding rounds from investors including Bpifrance, Impact Partners and Sofimac Investment Managers. Eurekam offers products and services including Drugcam Oncology and Drugcam Vaccine. Eurekam operates in a competitive market with competitors including House Rx, DecisionRx, GalenusRx, Prescription Advisory Systems & Technology and Pillcheck, among others.

  • Headquarter Lagord, France
  • Founders Loic Tamarelle, Benoit Le Franc
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website eurekam.fr
  • Social LinkedIn X
Key Metrics
  • Total Equity Funding
    $8.84M (USD)

    in 3 rounds

  • Latest Funding Round
    $6.34M (USD), Series B

    Oct 2022

  • Investors
    Bpifrance

    & 5 more

Products & Services of Eurekam

Eurekam offers a comprehensive portfolio of products and services, including Drugcam Oncology and Drugcam Vaccine.

Drugcam Oncology
AI Medication Safety

Ensures accurate preparation of cancer chemotherapy drugs

Drugcam Vaccine
AI Medication Safety

Facilitates safe production of vaccine doses

Funding Insights of Eurekam

Eurekam has successfully raised a total of $8.84M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.34 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $8.84M
  • Total Rounds 3
  • Last Round Series B β€” $6.34M
  • First Round $653,230

    (Jul 2013)

  • Investors Count 6

All 3 funding rounds of Eurekam with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2022$6.34MSeries B––
Apr 2018$1.84MSeries A––
Jul 2013$653,230Seed––
Valuation history

6 investors in total: 6 institutional.

Investors in Eurekam

Eurekam has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, Impact Partners and Sofimac Investment Managers.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
-
–sofimac-im.com-
Early to Growth stage VC & PE firm funding
–aquiti.frPessac, France
Private equity firm focused on multiple sectors
–swen-cp.frParis, France
-
–impact-partners.com-
A global body representing pharmacists and pharmaceutical scientists is operated.
–fip.orgThe Hague, Netherlands
Corporate consultancy, advisory, and funding services are provided to businesses.
2012bpifrance.comMaisons Alfort, France
Premium access

Investor details for Eurekam

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Eurekam

2 people are tracked at Eurekam (2 in leadership).

NameRoleGroup
Loic Tamarelle
Co-Founder & PresidentLeadership
Benoit Le Franc
Co-FounderLeadership
Premium access

Complete people profiles for Eurekam

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Eurekam

3 dated milestones of Eurekam across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Eurekam is founded.
  2. Funding First funding round of $653K.
  3. Funding Latest funding round, Series B, of $6.3M.

Competitors of Eurekam

Eurekam operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as House Rx, DecisionRx, GalenusRx, Prescription Advisory Systems & Technology and Pillcheck, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
houserx.com2005San Francisco, United States$29M–
Technology-based medication solutions are provided for patients and caregivers.
decisionrx.com2022Indianapolis, United States–11
Medication management solutions are provided to patients and healthcare providers.
galenusrx.com2023Fernandina Beach, United States$6.88M–
Medication safety risk management solutions are provided for healthcare organizations.
pastrx.com2013Jenkintown, United States$2.37M–
Software for Doctors to Help Treat Pain & Reduce Abuse of Controlled Substances
pillcheck.ca2013Vaughan, Canada––
DNA testing platform for user medication responses is offered.
pinscriptive.com2014San Juan Capistrano, United States$1.78M–
An analytics platform recommending specialty drugs for optimal health outcomes and value.
surveyorhealth.com2009San Mateo, United States$98,000–
Medication management solutions are provided for healthcare organizations.
ceuticare.com2007Toledo, United States––
Provides CCM software, health integration, and disease management for patients.
Premium access

Detailed competitors of Eurekam

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Eurekam

The website of Eurekam (eurekam.fr) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▲ 8.7% vs previous month

Latest news on Eurekam

Premium access

Complete news archive for Eurekam

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Eurekam

10 companies that operate in the same segment as Eurekam (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Eurekam

Eurekam was founded in 2012 and raised its 1st funding round 1 year after it was founded.

Eurekam is headquartered in Lagord, France. It is registered at Lagord, Charente-maritime, France.

Eurekam is a funded company, having raised a total of $8.84M across 3 funding rounds to date. The company's 1st funding round was a Seed of $653.23K, raised on Jul 2013.

Eurekam was founded in 2012 in Lagord, France, as a provider of medication management solutions in the oncology sector. An AI-based platform called DRUGCAM is offered, which uses video to prevent errors in chemotherapy treatments through monitoring of active substances, administration methods, and dosages for real-time validation. Additional tools support documentation of drug preparations and therapy management for clinical optimization.

Eurekam's top competitors include House Rx, DecisionRx and GalenusRx.

Eurekam offers Drugcam Oncology and Drugcam Vaccine.

Eurekam has 6 investors. Key investors include Bpifrance, Impact Partners, Sofimac Investment Managers, Aquiti Gestion, and FIP - International Pharmaceutical Federation.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available